Celcuity Inc. announced proposed underwritten public offerings of $150,000,000 Convertible Notes due 2031 and $75,000,000 of Common Stock. The Company intends to use the net proceeds for working capital, clinical trials, and general corporate purposes. The offerings are not conditioned upon each other and are subject to market conditions. Jefferies, TD Cowen, and Leerink Partners are acting as book-running managers. The Company expects to enter capped call transactions to reduce potential dilution. The offerings are detailed in a registration statement filed with the SEC. Forward-looking statements caution investors on risks and uncertainties.

Read more at GlobeNewswire: Celcuity Inc. Announces Concurrent Public Offerings of